BNP PARIBAS FINANCIAL MARKETS - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 95 filers reported holding STOKE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.14 and the average weighting 1.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$110,919
+42.8%
28,152
+285.4%
0.00%
Q2 2023$77,652
-13.5%
7,305
-32.2%
0.00%
Q1 2023$89,797
-69.2%
10,780
-65.8%
0.00%
Q4 2022$291,336
-99.9%
31,564
+84.5%
0.00%
Q3 2022$219,718,000
+15.7%
17,112
+19.0%
0.00%
Q2 2022$189,907,000
+448.4%
14,376
+773.9%
0.00%
Q1 2022$34,627,000
-64.5%
1,645
-59.6%
0.00%
Q4 2021$97,663,000
-76.3%
4,071
-74.9%
0.00%
-100.0%
Q3 2021$412,179,000
+1624.7%
16,202
+2182.0%
0.00%
Q2 2021$23,899,000
-85.3%
710
-83.0%
0.00%
Q1 2021$162,623,000
+34.5%
4,187
+114.5%
0.00%
Q4 2020$120,887,000
+24.6%
1,952
-32.6%
0.00%
Q3 2020$96,987,000
+469.2%
2,896
+305.0%
0.00%
Q2 2020$17,038,000
-85.7%
715
-86.3%
0.00%
Q1 2020$119,538,000
+234.5%
5,220
+313.6%
0.00%
Q4 2019$35,740,000
+43.6%
1,262
+9.0%
0.00%
Q3 2019$24,885,0001,1580.00%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 16,786,713$562,187,00075.80%
RTW INVESTMENTS, LP 3,544,248$118,697,0002.86%
Cormorant Asset Management, LP 1,537,807$51,501,0001.98%
Redmile Group, LLC 2,549,506$85,383,0001.57%
Birchview Capital, LP 40,000$1,340,0000.45%
HighVista Strategies LLC 17,082$572,0000.42%
Perceptive Advisors 671,978$22,505,0000.33%
GILDER GAGNON HOWE & CO LLC 1,490,153$49,905,0000.31%
Artal Group S.A. 270,750$9,067,0000.22%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 323$11,0000.20%
View complete list of STOKE THERAPEUTICS INC shareholders